Somapacitan for treating growth failure associated with being small for gestational age, Noonan syndrome or idiopathic short height [ID6536]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Somapacitan for treating growth failure caused by Turner syndrome in people 2 to 17 years [ID6621]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC